Shares of STERIS plc (STE) plummeted 6.37% on Wednesday, November 7, despite the company reporting better-than-expected earnings for the second quarter of fiscal 2025. The stock's decline suggests that investors were concerned about margin pressure and weaker-than-anticipated revenue growth.
The medical equipment and services provider reported adjusted earnings per share of $2.14, surpassing the consensus estimate of $2.12 and representing a 15.1% increase from the year-ago quarter. However, revenues of $1.33 billion fell slightly short of analysts' expectations of $1.33 billion, rising 7.3% year-over-year.
A key factor contributing to STERIS's stock price decline was the contraction in gross margin, which fell 56 basis points to 43.6% due to an 8.4% increase in the cost of revenues. The company's adjusted operating margin expanded by 127 basis points to 16.7%, but this improvement was not enough to alleviate investors' concerns about profitability pressures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.